Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.96 USD | +8.05% | +24.65% | -18.15% |
Apr. 15 | Morgan Stanley Adjusts Pharvaris' Price Target to $34 From $35, Keeps Overweight Rating | MT |
Apr. 12 | Pharvaris Files Mixed Shelf | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.15% | 1.14B | |
+1.24% | 43.84B | |
+6.60% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+7.59% | 25.53B | |
-24.73% | 18.18B | |
-3.35% | 12.29B | |
+27.66% | 12.29B | |
+7.47% | 11.15B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- SVB Securities Adjusts Price Target on Pharvaris to $20 From $25, Keeps Outperform Rating